531752 — Biogen Pharmachem Industries Balance Sheet
0.000.00%
Last trade - 00:00- IN₹619.97m
- IN₹599.81m
- 10
- 49
- 19
- 12
Annual balance sheet for Biogen Pharmachem Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.074 | 0.832 | 1.29 | 0.169 | 20.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 25.5 | 0.113 | 0.25 | 0.75 | 0.733 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 25.6 | 19.3 | 1.54 | 0.919 | 26.6 |
| Net Property, Plant And Equipment | 0 | 0 | 0 | — | 0 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 543 | 549 | 548 | 568 | 920 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.08 | 8.15 | 2.38 | 3.02 | 0.9 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 1.08 | 8.15 | 2.38 | 3.02 | 0.9 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 541 | 541 | 546 | 565 | 919 |
| Total Liabilities & Shareholders' Equity | 543 | 549 | 548 | 568 | 920 |
| Total Common Shares Outstanding |